<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24068141</article-id>
      <article-id pub-id-type="pmc">3760945</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132138</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Soft-tissue masses as presentation of non-Hodgkin's lymphoma in AIDS
patients<xref ref-type="fn" rid="fn01">*</xref></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Massas de tecidos moles como apresenta&#xE7;&#xE3;o do linfoma n&#xE3;o-Hodgkin em
pacientes com AIDS</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Corti</surname>
            <given-names>Marcelo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Villafa&#xF1;e</surname>
            <given-names>Mar&#xED;a Florencia</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bistmans</surname>
            <given-names>Alicia</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campitelli</surname>
            <given-names>Ana</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narbaitz</surname>
            <given-names>Marina</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Head of HIV/AIDS Department, Infectious Diseases, F. J. Mu&#xF1;iz Hospital
- Buenos Aires, Argentina - Professor of Internal Medicine Department - Infectious Diseases
Orientation - Faculty of Medicine - University of Buenos Aires (UBA) - Buenos Aires,
Argentina.</aff>
      <aff id="aff02"><label>2</label> Infectologist, Unit 10 HIV/AIDS Division, Infectious Diseases, F. J.
Mu&#xF1;iz Hospital - Buenos Aires, Argentina.</aff>
      <aff id="aff03"><label>3</label> Oncologist, Oncology Unit, Ramos Mej&#xED;a Hospital - Buenos Aires,
Argentina.</aff>
      <aff id="aff04"><label>4</label> Pathologist, Pathology Laboratory, Infectious Diseases, F. J. Mu&#xF1;iz
Hospital, Buenos Aires, Argentina.</aff>
      <aff id="aff05"><label>5</label> Pathologist, Pathology Laboratory, National Academy of Medicine -
Buenos Aires, Argentina.</aff>
      <author-notes>
        <corresp id="c01"><bold>MAILING ADDRESS:</bold> Marcelo Corti Pu&#xE1;n, 381, 2&#xBA; C1406 - Buenos Aires
Argentina. E-mail: <email>marcelocorti@fibertel.com.ar</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>4</issue>
      <fpage>631</fpage>
      <lpage>634</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Primary soft tissue Non-Hodgkin lymphomas are very rare and account only for 0.1 % of
the cases. Generally, Non-Hodgkin lymphomas of the soft tissue present as large
subcutaneous masses without evidence of nodal or skin involvement. We describe four
cases of primary Non-Hodgkin lymphomas of the soft tissue in patients infected with
the human immunodeficiency virus. The most common site of involvement was the chest
wall in all the patients; histopathological and immunophenotypic examination of the
biopsy smears revealed two cases of plasmablastic lymphomas, one Burkitt and one
diffuse large B-cell lymphoma. Non-Hodgkin lymphomas should be included in the
differential diagnosis of soft tissue masses in human immunodeficiency virus -
seropositive patients.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Os linfomas N&#xE3;o-Hodgkin prim&#xE1;rios de tecidos moles s&#xE3;o muito raros e respons&#xE1;veis por
somente 0,1% dos casos. Geralmente, os linfomas N&#xE3;o-Hodgkin de tecidos moles se
apresentam como massas subcut&#xE2;neas sem evid&#xEA;ncia de comprometimento dos n&#xF3;dulos ou da
pele. Descrevemos aqui quatro casos de linfomas N&#xE3;o-Hodgkin prim&#xE1;rio de tecidos moles
em pacientes infectados pelo v&#xED;rus da imunodefici&#xEA;ncia humana. O local mais comum de
comprometimento foi a parede tor&#xE1;cica em todos os pacientes; os exames
histopatol&#xF3;gico e imunofenot&#xED;pico do esfrega&#xE7;o da bi&#xF3;psia revelaram dois casos de
linfoma plasmabl&#xE1;stico, um linfoma de Burkitt e um linfoma difuso de grandes c&#xE9;lulas
B. O linfoma N&#xE3;o-Hodgkin deve ser inclu&#xED;do no diagn&#xF3;stico diferencial de massas de
tecidos moles nos pacientes soropositivos para v&#xED;rus da imunodefici&#xEA;ncia humana.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Acquired immunodeficiency syndrome</kwd>
        <kwd>HIV</kwd>
        <kwd>Lymphoma, B-Cell</kwd>
        <kwd>Lymphoma, Non-Hodgkin</kwd>
        <kwd>Soft tissue neoplasms</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>The risk of developing lymphomas is greatly increased in HIV infected patients. AIDS
associated lymphomas are characterized by their rapid progression, frequent extranodal
initial manifestations and poor outcome.1 The incidence of extranodal non- Hodgkin's
lymphomas (NHL) in HIV/AIDS patients is 3%; soft tissue involvement is rare and is
described only in 0.1% of the cases.1 In this article, we reviewed the epidemiological,
clinical, histopathological, immunological, virological and the outcome of four HIV/AIDS
patients with soft tissue masses as clinical presentation of NHL.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>The patients were clinically staged according to the Ann Arbor system. Primary NHL of
the soft tissue was defined as those lymphomas presenting with involvement of the soft
tissue or the muscle as the predominant manifestation of the disease. Patients with
cutaneous or bone tissue involvement were excluded. All diagnoses were performed by
histopathological examination of biopsy smears obtained from the soft tissue masses.
Histopathological diagnosis was made according to the criteria of the World Health
Organization (WHO).<sup><xref ref-type="bibr" rid="B02">2</xref></sup>Immunohistochemical stains were applied in all cases. During an 11-year
period analyzed in our hospital for infectious diseases, 92 HIV-infected patients were
diagnosed with lymphoma. Sixty-six (72%) of them had NHL and 26 (28%) had Hodgkin's
disease. Of 66 NHL, 41 (64%) were extranodal NHL and 4 (0.09%) were soft tissue primary
NHL. All were males with a median of age of 41 years. Clinical presentation showed
painless and large subcutaneous masses with rapidly increasing size. Two patients with
history of intravenous drug use (IVDUs) had antibodies against hepatitis C virus (HCV)
and the other 2 presented positive hepatitis B (HBV) serology. Lactate dehydrogenase
(LDH) levels were elevated in the 4 patients and only one patient (25%) had evidence of
bone marrow infiltration. Sites of involvement included the chest wall in all of them
(<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>) with other masses in the upper leg and the scalp in two.
Histopathological and immunophenotype studies revealed 2 plasmablastic lymphomas (PBL),
1 diffuse large B cell lymphoma (DLBCL) and 1 Burkitt lymphoma (BL). Two patients died
after a short survival time following lymphoma diagnosis due to an aggressive and rapid
clinical course of the neoplasm and disseminated tuberculosis, respectively, without the
possibility of receiving chemotherapy because of his poor clinical status. One patient
died 12 months later of unrelated cause and the other is alive. Demographic and clinical
findings are summarized in <xref ref-type="table" rid="t01">tables 1</xref> and <xref ref-type="table" rid="t02">2</xref>.</p>
      <fig id="f01" fig-type="other" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>A large mass involving soft tissues in the chest wall, without compromising the
skin or axillary lymphadenopathy</p>
        </caption>
        <graphic xlink:href="abd-88-0631-g01"/>
      </fig>
      <fig id="f02" fig-type="other" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>A subcutaneous tumor located on the chest wall.</p>
        </caption>
        <graphic xlink:href="abd-88-0631-g02"/>
      </fig>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>TABLE 1</label>
        <caption>
          <p>Demographic findings in four cases of soft tissue lymphomas from AIDS patients</p>
        </caption>
        <table frame="hsides" rules="groups">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;</td>
              <td rowspan="1" colspan="1">
                <bold>1</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>2</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>3</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>4</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Gender</bold>
              </td>
              <td rowspan="1" colspan="1">male</td>
              <td rowspan="1" colspan="1">male</td>
              <td rowspan="1" colspan="1">male</td>
              <td rowspan="1" colspan="1">male</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Age</bold>
              </td>
              <td rowspan="1" colspan="1">35</td>
              <td rowspan="1" colspan="1">46</td>
              <td rowspan="1" colspan="1">37</td>
              <td rowspan="1" colspan="1">48</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>HIV/risk infection</bold>
              </td>
              <td rowspan="1" colspan="1">IVDUs</td>
              <td rowspan="1" colspan="1">IVDUs</td>
              <td rowspan="1" colspan="1">Unprotected sexual contact</td>
              <td rowspan="1" colspan="1">Unprotected sexual contact</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Clinical Stage</bold>
              </td>
              <td rowspan="1" colspan="1">Advanced</td>
              <td rowspan="1" colspan="1">Advanced</td>
              <td rowspan="1" colspan="1">Advanced</td>
              <td rowspan="1" colspan="1">Advanced</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>HBV</bold>
              </td>
              <td rowspan="1" colspan="1">(-)</td>
              <td rowspan="1" colspan="1">(-)</td>
              <td rowspan="1" colspan="1">(+)</td>
              <td rowspan="1" colspan="1">(+)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>HCV</bold>
              </td>
              <td rowspan="1" colspan="1">(+)</td>
              <td rowspan="1" colspan="1">(+)</td>
              <td rowspan="1" colspan="1">(-)</td>
              <td rowspan="1" colspan="1">(-)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>LDH (U/L)</bold>
              </td>
              <td rowspan="1" colspan="1">1280</td>
              <td rowspan="1" colspan="1">786</td>
              <td rowspan="1" colspan="1">926</td>
              <td rowspan="1" colspan="1">1518</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Bone marrow involvement</bold>
              </td>
              <td rowspan="1" colspan="1">(+)</td>
              <td rowspan="1" colspan="1">(-)</td>
              <td rowspan="1" colspan="1">(-)</td>
              <td rowspan="1" colspan="1">(-)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="t02" orientation="portrait" position="float">
        <label>TABLE 2</label>
        <caption>
          <p>Immunological, histopathological and virological findings from AIDS patients with
soft tissue lymphomas</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;</td>
              <td rowspan="1" colspan="1">
                <bold>1</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>2</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>3</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>4</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Location</bold>
              </td>
              <td rowspan="1" colspan="1">Chest wall and upper leg</td>
              <td rowspan="1" colspan="1">Chest wall</td>
              <td rowspan="1" colspan="1">Chest wall, scalp</td>
              <td rowspan="1" colspan="1">Chest wall</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>CD4 level (cell/uL)</bold>
              </td>
              <td rowspan="1" colspan="1">37</td>
              <td rowspan="1" colspan="1">357</td>
              <td rowspan="1" colspan="1">56</td>
              <td rowspan="1" colspan="1">201</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Plasma Viral Load</bold>
              </td>
              <td rowspan="1" colspan="1">Detectable</td>
              <td rowspan="1" colspan="1">Undetectable</td>
              <td rowspan="1" colspan="1">Detectable</td>
              <td rowspan="1" colspan="1">Undetectable</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Histological subtype</bold>
              </td>
              <td rowspan="1" colspan="1">Plasmablastic lymphoma</td>
              <td rowspan="1" colspan="1">Diffuse large B cell lymphoma (DLBCL)</td>
              <td rowspan="1" colspan="1">Plasmablastic lymphoma</td>
              <td rowspan="1" colspan="1">Burkitt's lymphoma</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Survival</bold>
              </td>
              <td rowspan="1" colspan="1">1 month</td>
              <td rowspan="1" colspan="1">6 months</td>
              <td rowspan="1" colspan="1">1 month</td>
              <td rowspan="1" colspan="1">12 months</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Treatment</bold>
              </td>
              <td rowspan="1" colspan="1">None</td>
              <td rowspan="1" colspan="1">CHOP-R plus HAART</td>
              <td rowspan="1" colspan="1">none</td>
              <td rowspan="1" colspan="1">CHOP-R plus HAART</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Response</bold>
              </td>
              <td rowspan="1" colspan="1">None</td>
              <td rowspan="1" colspan="1">Partial</td>
              <td rowspan="1" colspan="1">None</td>
              <td rowspan="1" colspan="1">Partial</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Cause of death</bold>
              </td>
              <td rowspan="1" colspan="1">Lymphoma progression</td>
              <td rowspan="1" colspan="1">Alive</td>
              <td rowspan="1" colspan="1">Disseminated tuberculosis</td>
              <td rowspan="1" colspan="1">Sepsis with multiorganic failure</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The incidence of NHL including DLBCL, Burkitt's lymphoma and PBL is increased among
HIVseropositive patients and 16% of deaths in AIDS patients have been associated with
lymphomas.<sup><xref ref-type="bibr" rid="B02">2</xref></sup>The incidence of NHL
in HIV patients is 3% and the lesions usually are of high-grade and with extranodal
involvement as clinical presentation. About 70% of AIDS-associated lymphomas are
NHL.<sup><xref ref-type="bibr" rid="B01">1</xref>,<xref ref-type="bibr" rid="B02">2</xref></sup>The incidence of extranodal NHL of the soft tissues is low and
account only for 0.1% of the cases.<sup><xref ref-type="bibr" rid="B03">3</xref>,<xref ref-type="bibr" rid="B04">4</xref></sup>Soft tissue lymphomas at presentation are
considered to be primary only if the staging procedures exclude other disease
sites.<sup><xref ref-type="bibr" rid="B03">3</xref></sup>Soft tissue lymphomas
include those masses that involve the subcutaneous and the musculoskeletal tissues; in
our experience, these neoplasms are characterized by fast growth with frequent
involvement of the adjacent tissues, such as the skin and bone (<xref ref-type="fig" rid="f03">Figure 3</xref>).<sup><xref ref-type="bibr" rid="B03">3</xref></sup></p>
      <fig id="f03" fig-type="other" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>A large soft tissue mass involving the subcutaneous and musculoskeletal tissue on
the chest wall. There is no evidence of regional nodal infiltration.</p>
        </caption>
        <graphic xlink:href="abd-88-0631-g03"/>
      </fig>
      <p>Salamao et al describes a clinic pathologic study of 19 patients who developed lymphomas
as soft tissue masses without evidence of lymph node involvement.<sup><xref ref-type="bibr" rid="B04">4</xref></sup>The authors conclude that malignant
lymphomas initially diagnosed in soft tissues are most commonly DLBCL. In contrast, 2
patients of our series had diagnosis of the histopathological subtype named as PBL.
These are rare tumors occurring almost exclusively in the setting of HIV infection. PBL
was recognized as a distinct entity, a subtype of DLBCL, in the World Health
Organization (WHO) classification; one was a BL and the last was a DLBCL.<sup><xref ref-type="bibr" rid="B05">5</xref>,<xref ref-type="bibr" rid="B06">6</xref></sup></p>
      <p>Cutaneous B-cell lymphomas have been also described in HIV patients as red skin nodules
in the arms, head and trunk. These lesions usually start in the skin and may involve
subcutaneous tissues.<sup><xref ref-type="bibr" rid="B07">7</xref></sup></p>
      <p>In our experience, ultrasound of musculoskeletal tissue provides valuable information
about the extent of the mass.<sup><xref ref-type="bibr" rid="B08">8</xref>,<xref ref-type="bibr" rid="B09">9</xref></sup></p>
      <p>Advanced neoplasm disease at presentation, bone marrow infiltration, prior diagnosis of
AIDS and a poor performance status are associated with a shorter survival in
HIV-patients associated NHL, as we can see in our series.<sup><xref ref-type="bibr" rid="B10">10</xref></sup></p>
      <p>Early excision biopsy is necessary to confirm the diagnosis of these neoplasms and to
determine the histopathological subtype.</p>
      <p>Chemotherapy and/or radi otherapy are the best therapeutic alternatives for NHL of the
soft tissues; however, some authors have published a good clinical outcome in patients
treated with a wide surgical excision followed by chemotherapy.<sup><xref ref-type="bibr" rid="B09">9</xref></sup></p>
      <p>The impact of highly active antiretroviral therapy (HAART) on NHL response and survival
rates has been well demonstrated in several studies. Patients receiving HAART plus
chemotherapy have a more significant opportunity to achieve complete
remission.<sup><xref ref-type="bibr" rid="B10">10</xref></sup>In our series, the 2
patients treated with chemotherapy plus HAART had a partial clinical response.</p>
      <p>Early diagnosis followed by chemotherapy plus HAART is necessary to achieve a good
clinical outcome in this kind of patients.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work carried out at the Infectious Diseases Laboratory, F. J. Mu&#xF1;iz Hospital -
Buenos Aires, Argentina.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tirelli</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Spina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gaidano</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vaccer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Franceschi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carbone</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Epidemiological, biological and clinical features of HIV-related
lymphomas in the era of highly active antiretroviral therapy</article-title>
          <source>AIDS</source>
          <year>2000</year>
          <volume>14</volume>
          <fpage>1675</fpage>
          <lpage>1688</lpage>
          <pub-id pub-id-type="pmid">10985303</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Brodt</surname>
              <given-names>H-R</given-names>
            </name>
            <name>
              <surname>Fichtlscherer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mantzsch</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hoelzer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>EB</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Changing incidence and prognostic factors of survival in AIDS-related
nonHodgkin's lymphoma in the era of highly active antiretroviral therapy
(HAART)</article-title>
          <source>Leuk Lymphoma</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>207</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="pmid">15621803</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Reiman</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Primary extranodal soft tissues lymphoma of
extremities</article-title>
          <source>Am J Surg Pathol.</source>
          <year>1987</year>
          <volume>11</volume>
          <fpage>359</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="pmid">3578646</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salamao</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Habermann</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Strickler</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Lymphoma in soft tissue: a clinicopathologic study of 19
cases</article-title>
          <source>Hum Pathol</source>
          <year>1996</year>
          <volume>27</volume>
          <fpage>253</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">8600039</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delecleuse</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Anagnostopopous</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dallencbach</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hummel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marafioti</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Plasmablastic lymphomas of the oral cavity: a new entity associated
with the human immunodeficiency virus infection</article-title>
          <source>Blood</source>
          <year>1987</year>
          <volume>89</volume>
          <fpage>1413</fpage>
          <lpage>1423</lpage>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>de Dios Soler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bar&#xE9;</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Villafa&#xF1;e</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>De Tezanos Pinto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez Bianco</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>AIDS related lymphomas: Histopathological subtypes and association
with Epstein Barr and Human Herpes virus type-8</article-title>
          <source>Medicina (B Aires)</source>
          <year>2010</year>
          <volume>70</volume>
          <fpage>151</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">20447898</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Carolis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Solari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Villafa&#xF1;e</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Schtirbu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lewi</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Non Hodgkin's lymphoma with cutaneous involvement in AIDS patients.
Report of five cases and review of the literature</article-title>
          <source>Br J Infect Dis</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>81</fpage>
          <lpage>85</lpage>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinare</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brahmnalkar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>D'Costa</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Ultrasound of muskuloskeletal of soft tissue masses</article-title>
          <source>Indian J Radiol Imaging.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>201</fpage>
          <lpage>208</lpage>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belaabidia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sellami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hamdaoui</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Essadki</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Primary malignant non-Hodgkin skeletal muscle lymphoma: a case
report</article-title>
          <source>Rev Chir Orthop Reparatrice Appar Mot</source>
          <year>2002</year>
          <volume>88</volume>
          <fpage>18</fpage>
          <lpage>21</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Recent advances in Acquired Immunodeficiency syndrome (AIDS)-related
lymphoma</article-title>
          <source>Cancer J Clin</source>
          <year>2005</year>
          <volume>55</volume>
          <fpage>229</fpage>
          <lpage>241</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
